Robert J Bitterman insider trades

Open-market stock purchases and sales by Robert J Bitterman, Chairman, Pres. & CEO at Phio Pharmaceuticals Corp, from SEC Form 4 filings since Jun 7, 2013.

Track record: 50% of 18 scored buys are up 5% or more since purchase, averaging +24%.

Recent trades

DateStockTradeValue
Jun 26, 2026PHIO Phio Pharmaceuticals CorpBought$9.9K
Feb 5, 2026PHIO Phio Pharmaceuticals CorpBought (not open market)—
Dec 31, 2025PHIO Phio Pharmaceuticals CorpBought$5.2K
Dec 23, 2025PHIO Phio Pharmaceuticals CorpBought$5.1K
Nov 21, 2025PHIO Phio Pharmaceuticals CorpBought$5.7K
Nov 18, 2025PHIO Phio Pharmaceuticals CorpBought$6.3K

Companies traded

  • PHIO Phio Pharmaceuticals Corp: 20 buys, last Jun 26, 2026
  • RXII RXi Pharmaceuticals Corp: 6 buys, last Aug 1, 2018

Get free alerts when Robert J Bitterman files a new trade →